191 related articles for article (PubMed ID: 19276285)
1. Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer.
Sehl ME; Langer LR; Papp JC; Kwan L; Seldon JL; Arellano G; Reiss J; Reed EF; Dandekar S; Korin Y; Sinsheimer JS; Zhang ZF; Ganz PA
Clin Cancer Res; 2009 Mar; 15(6):2192-203. PubMed ID: 19276285
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in genes interacting with BRCA1/2 and risk of breast cancer in the Cypriot population.
Loizidou MA; Cariolou MA; Neuhausen SL; Newbold RF; Bashiardes E; Marcou Y; Michael T; Daniel M; Kakouri E; Papadopoulos P; Malas S; Hadjisavvas A; Kyriacou K
Breast Cancer Res Treat; 2010 May; 121(1):147-56. PubMed ID: 19714462
[TBL] [Abstract][Full Text] [Related]
4. Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.
Yu KD; Di GH; Li WF; Rao NY; Fan L; Yuan WT; Hu Z; Wu J; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 May; 121(1):157-67. PubMed ID: 19728081
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.
Silva SN; Tomar M; Paulo C; Gomes BC; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
Cancer Epidemiol; 2010 Feb; 34(1):85-92. PubMed ID: 20004634
[TBL] [Abstract][Full Text] [Related]
6. A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.
Kadouri L; Kote-Jarai Z; Hubert A; Durocher F; Abeliovich D; Glaser B; Hamburger T; Eeles RA; Peretz T
Br J Cancer; 2004 May; 90(10):2002-5. PubMed ID: 15138485
[TBL] [Abstract][Full Text] [Related]
7. DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR).
Wu HC; Delgado-Cruzata L; Machella N; Wang Q; Santella RM; Terry MB
Cancer Causes Control; 2013 Dec; 24(12):2157-68. PubMed ID: 24062231
[TBL] [Abstract][Full Text] [Related]
8. Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk.
Baynes C; Healey CS; Pooley KA; Scollen S; Luben RN; Thompson DJ; Pharoah PD; Easton DF; Ponder BA; Dunning AM;
Breast Cancer Res; 2007; 9(2):R27. PubMed ID: 17428325
[TBL] [Abstract][Full Text] [Related]
9. Variants in DNA double-strand break repair genes and breast cancer susceptibility.
Kuschel B; Auranen A; McBride S; Novik KL; Antoniou A; Lipscombe JM; Day NE; Easton DF; Ponder BA; Pharoah PD; Dunning A
Hum Mol Genet; 2002 Jun; 11(12):1399-407. PubMed ID: 12023982
[TBL] [Abstract][Full Text] [Related]
10. Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.
Sigurdson AJ; Hauptmann M; Chatterjee N; Alexander BH; Doody MM; Rutter JL; Struewing JP
BMC Cancer; 2004 Mar; 4():9. PubMed ID: 15113441
[TBL] [Abstract][Full Text] [Related]
11. BRCA1 and BRCA2: breast/ovarian cancer susceptibility gene products and participants in DNA double-strand break repair.
O'Donovan PJ; Livingston DM
Carcinogenesis; 2010 Jun; 31(6):961-7. PubMed ID: 20400477
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility.
Fu YP; Yu JC; Cheng TC; Lou MA; Hsu GC; Wu CY; Chen ST; Wu HS; Wu PE; Shen CY
Cancer Res; 2003 May; 63(10):2440-6. PubMed ID: 12750264
[TBL] [Abstract][Full Text] [Related]
13. Mismatch Repair Polymorphisms as Markers of Breast Cancer Prevalence in the Breast Cancer Family Registry.
Kappil M; Terry MB; Delgado-Cruzata L; Liao Y; Santella RM
Anticancer Res; 2016 Sep; 36(9):4437-41. PubMed ID: 27630279
[TBL] [Abstract][Full Text] [Related]
14. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
15. DNA repair variants and breast cancer risk.
Grundy A; Richardson H; Schuetz JM; Burstyn I; Spinelli JJ; Brooks-Wilson A; Aronson KJ
Environ Mol Mutagen; 2016 May; 57(4):269-81. PubMed ID: 27060854
[TBL] [Abstract][Full Text] [Related]
16. Germline RAP80 mutations and susceptibility to breast cancer.
Akbari MR; Ghadirian P; Robidoux A; Foumani M; Sun Y; Royer R; Zandvakili I; Lynch H; Narod SA
Breast Cancer Res Treat; 2009 Jan; 113(2):377-81. PubMed ID: 18306035
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China.
Wu Z; Wang P; Song C; Wang K; Yan R; Li J; Dai L
Mol Genet Genomics; 2015 Jun; 290(3):1141-53. PubMed ID: 25566853
[TBL] [Abstract][Full Text] [Related]
18. Involvement of MRE11A and XPA gene polymorphisms in the modulation of DNA double-strand break repair activity: a genotype-phenotype correlation study.
Ricceri F; Porcedda P; Allione A; Turinetto V; Polidoro S; Guarrera S; Rosa F; Voglino F; Pezzotti A; Minieri V; Accomasso L; Cibrario Rocchietti E; Orlando L; Giachino C; Matullo G
DNA Repair (Amst); 2011 Oct; 10(10):1044-50. PubMed ID: 21880556
[TBL] [Abstract][Full Text] [Related]
19. A role for XRCC4 in age at diagnosis and breast cancer risk.
Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
[TBL] [Abstract][Full Text] [Related]
20. Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer.
Couch FJ; Shimelis H; Hu C; Hart SN; Polley EC; Na J; Hallberg E; Moore R; Thomas A; Lilyquist J; Feng B; McFarland R; Pesaran T; Huether R; LaDuca H; Chao EC; Goldgar DE; Dolinsky JS
JAMA Oncol; 2017 Sep; 3(9):1190-1196. PubMed ID: 28418444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
